About Rebecca Gordon, MD

Rebecca Gordon, MD, is a pediatric endocrinologist with particular interests in calcium and bone metabolism. She completed pediatric residency at Albert Einstein and a fellowship in pediatric endocrinology at Columbia University. She is the Co-director of the pediatric Bone and Mineral Metabolism Clinic. 

Dr. Gordon is active in clinical research investigating suboptimal bone accrual in growing children and secondary causes of pediatric osteoporosis. She has a strong interest in bone health in patients with inflammatory bowel disease and cystic fibrosis.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Brigham for Children: Pediatric Endocrine Program and Diabetes Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2909

Mass General Brigham for Children at Newton-Wellesley Hospital
2014 Washington St.
Newton, MA 02462
Phone: 617-243-6585

Medical Education

  • MD, University Of Vermont
  • Residency, Albert Einstein College of Medicine
  • Fellowship, Columbia University New York Presbyterian Hospital

American Board Certifications

  • Pediatric Endocrinology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Gordon's clinical and translational research focuses on pediatric and adolescent bone health. While many pediatric diseases can adversely affect bone accrual, little is known about how children and adolescents accrue their peak bone mass within the setting of several chronic diseases. She is currently investigating bone accrual in children with Crohn's disease and cystic fibrosis, two diseases known to adversely affect bone health. Her goals are to better understand the roles of these diseases and other chronic inflammatory and nutritional diseases on pediatric bone health and apply pathophysiologic insights to develop targeted and effective therapeutic interventions to decrease bone fragility in these patient populations. Additionally, Dr. Gordon has studied vitamin D supplementation in patients with inflammatory bowel disease, and she is interested in rare disorders of bone and mineral metabolism.

Publications

Reviews: Comments and Ratings